Plasmodium falciparuin malaria is a leading showed good activity against P. berghei infeccause of morbidity and mortality in developing tions in mice. 5 The choice by the World Health countries.' Because of the widespread resistance Organization of arteether over artemether was of malaria parasites to currently available based on the consideration that arreether would drugs, '-3 there is an urgent need for new ones. be more lipophilic, a possible advantage for its Over the past decade, a novel class of com-accumulation in brain tissues in patients with pounds based on artemisinin (qinghaosu) (Fig-cerebral malaria . It was also considered to be ure Ia), a naturally-occurring. 15-carbon lac-potentially less toxic because one of its putative tone endoperoxide, has been found to be effective metabolites would be ethanol rather than methagainst the erythrocytic stage of chloroquine-anol. 7 In addition, the 3 anomer of arteether, sensitive and chloroquine-resistant strains of P. which is a crystalline solid, was chosen because falciparum. 4 When artemether. the methyl ether it is the predominant anomer upon synthesis derivative of dihydroartemisinin (DHA) (Fig-and is relatively easy to separate from the a ure I b) is synthesized, it yields two crystalline anomer, which is a liquid (Figure I e), a potential anomers, i.e., a-and 0-artemether ( Figure Ic advantage for large-scale production. The comand d, respectively). The latter anomer predombination of the two anomers cannot be readily inates and is marginally more active against P. developed as a drug in the United States because berghei. 5 O-Artemether has been demonstrated of regulatory considerations as long as their poby Chinese investigators to be effective against tencies, toxicities. and pharmacokinetic propchloroquine-resistant P. falciparum malaria in erties have not been shown to be comparable. humans, 6 and it is currently available for clin-Preclinical studies have been performed jointly ical use in China and a few other countries in by the Walter Reed Army Institute of Research Southeast Asia. and the World Health Organization. Early in 1985, the World Health Organization
In this report, we compare the activity of f-arselected another derivative of DHA for devel-temether and 3-arteether in three test systems opment outside China. This compound was the that are used for preclinical evaluation of po-$i-ethyl ether anomer of DHA ( Figure I f Plasmodium falciparum in vitro test system infected mice. The drugs were prepared by dissolving them in sesame oil (USP), the formuThe antimalarial activities of artemisinin. a lation of 0-arteether intended for clinical use, and 0 anomers of artemether and arteether. and or peanut oil (USP). the formulation of $-ar-DHA were assessed in vitro relative to the ac-temether in clinical use and the usual solvent tivities ofchloroquine. mefloquine. and quinine used in the mouse test system. Starting at a dose in the semiautomated microdilution method of of 640 mg/kg, each drug was administered in Desjardins and others, 8 as modifie , by Milhous three graded doses diluted four-fold to groups and others.' In this assay, the activity of a can-of five or 10 mice per dose level. Once a drug didate compound is tested for its ability to in-showed activity on initial screening, it was fur-ther tested at additional dose levels obtained by istered at alternating sites along the left and right two-fold dilution. The tests were performed at thigh muscles. The initial concentration of the successively lower doses until the lower limit of drugs was 100 mg/ml; the drugs were diluted activity was reached. Young, untreated, control with additional sesame oil (USP), as approprimice injected with a standard inoculum of P. ate, to yield the assigned doses. For each exberghei have a survival time of 6.8 ± 0.5 days perimental group, several untreated monkeys (mean ± SD).
were followed to verify the course of untreated The curative antimalarial activity of 0-artem-infections. They were, however, treated with ether and 0-arteether was measured in either mefloquine (30 mg/kg of base) when they bemale or female mice weighing 18-22 g that were came moribund. injected intraperitoneally with 0.02 ml of hepParasite counts were determined by the Earlearinized blood containing with 6 x I0' eryth-Perez method. ' 3 Parasitemia was monitored rocytes parasitized with P. berghei. The drugs daily until the thick blood films were negative were administered subcutaneously 72 hr after for at least seven consecutive days; thereafter. inoculation. By that time, the infection is well blood films were monitored twice a week. If established and presents candidate compounds recrudescence occurred, blood films were exwith a standardized challenge. In each experi-amined daily. Treated monkeys, whose parasite ment, there were 15 untreated control mice and counts continued to increase for several days 10 pyrimethamine-treated (120 mg/kg) control after treatment, and monkeys whose parasitmice. The control mice were included to check emia recrudesced were treated with mefloquine. for infectivity of P. berghei. change in the sus-After blood films showed no evidence of paraceptibility of the host, or procedural errors. Sur-sites for 100 days, the infection was considered viving mice were monitored daily for 60 days cured. Response to treatment was categorized at which time they were considered cured.
as clearance and cure, clearance and recrudescence, or suppression without clearance. The Plasmodium falciparum-Aotus monkey test day of clearance was defined as the first of three system consecutive days in which the thick blood films were parasite negative. The day of recrudesIn this model, the activity of a compound is cence was the first of three consecutive days of measured by its ability to cure adult Panaman-positive thick blood films after a period of clearian owl monkeys (Aotus lemurinus lemurinus) ance. Suppression was defined as a transient deof both sexes infected with the Vietnam Smith/ crease in the parasite count post-treatment RE strain of P. falciparum. Fifty-eight monkeys without clearance. weighing 750-950 g were randomly assigned to After a preliminary toxicity and tolerance receive l-artemether or 0-arteether dissolved in study confirmed that a total dose of 192 mg/kg sesame oil (USP). Infections were induced in given in three divided dosages 12 hr apart was accordance with published procedures.' 0 Brief-well tolerated in noninfected monkeys, addily, 0.5-1.0 ml of blood was drawn from the tional monkeys were treated at this same dose femoral artery of an untreated monkey infected and at lower dose levels until a dose was reached with the Vietnam Smith/RE strain of P. falcip-in which suppression or clearance was no longer arum, using 2.5% sodium citrate as an antico-accompanied by cure. agulant, and diluted with 0.85% saline solution to form a suspension containing 5 x 106 tro-Data analysis phozoites/ml. One milliliter of the suspension was then injected into the saphenous vein of the A four parameter logistic model was fitted to experimental and control monkeys. Beginning the radioactivity count versus the log drug conwith the first postinoculation day, Giemsa-centration of each in vitro assay. The model stained blood films were prepared and examincludes a parameter, the 50% inhibitory conined daily; by the fifth postinoculation day the centration (IC 50 ), corresponding to the drug parasitemia was well established. The drug was concentration yielding an expected count of raadministered intramuscularly in three equal diolabeled 3 H-hypoxanthine midway between doses at 12-hr intervals starting on the fifth day the upper asymptote (as the drug concentration postinoculation. These injections were admin-approaches zero) and lower asymptote (expect- ., -compound relative to another were based on . system, the overall parallelism of dose response = 00 r-00 V curves (percent cure versus log dose) was tested.
Ifno significant departure from parallelism was detected, reported potencies and 95% CI were based on the estimated common slope. Data on 0 --r -9 time to clearance and time to recrudescence are The 0 anomers of artemether and arteether E showed comparable activity against both drug-C,._ . sensitive and drug-resistant P. falciparum clones 7" in the in vitro test system ( Table 1 ). The mean a anomer of arteether may be somewhat less showed a precipitous decrease in the parasite potent. count within one to two days after initiation of d-Arteether was approximately five-fold more treatment. By one week after treatment, the parpotent than mefloquine and approximately 90-asites were usually barely detectable. Monkeys fold more potent than chloroquine against the treated with subcurative doses showed a tranchloroquine-resistant W-2 clone of P. falcipa-sient decrease in the parasite count that lasted rum parasites. O-Arteether was also more active several days after which the parasitemia rethan mefloquine and chloroquine against the sumed its upward trend. The typical rates of the Vietnam Smith/RE clone of P. falciparum decrease of parasitemia for fl-artemether and parasites by nine-fold and 77-fold, respectively. 0-arteether were indistinguishable. The clearIt was approximately 11-fold more potent than ance times for 0-artemether and 0-arteether were mefloquine and approximately 2.5-fold more 8.3 ± 1.7 and 7.5 ± 1.9 days (mean ± SD), potent than chloroquine against the chlororespectively. Although parasitemia was supquine-sensitive D-6 clone, pressed in all monkeys receiving a total dose of Interestingly, DHA consistently showed the 0.75 mg/kg of either 0-artemether or t-artegreatest activity among the compounds tested. ether, none were cured (Table 3 ). In monkeys It had a mean IC, 0 of approximately 0.9 nM receiving 3 mg/kg, parasitemia cleared in four (range 0.88-1.02 nM), which exceeds the activof four monkeys treated with 0-arteether and in ities of artemisinin by approximately 4.5-fold three of four treated with 0-artemether: howand 0-arteether by approximately two-fold. ever, only one infection treated with 0-arteether was cured. In all monkeys receiving 12 mg/kg, Plasmodium berghei-mouse test system parasitemia cleared but recrudesced in two of eight monkeys treated with 0-artemether and in O-Artemether and 0-arteether showed comfour of eight treated with 0-arteether. Parasitparable efficacy against P. berghei whether dis-emia cleared in all monkeys treated with 24 mg/ solved in peanut or sesame oil (0-arteether) or kg but recrudesced in two of four treated with only in sesame oil (fl-artemether) and whether 0-arteether. At dosages of 48 mg/kg and 192 administered to male or female mice. These mg/kg, all infections were cured. The number compounds had a mean CD,, value of 55 mg/ of days to recrudescence for both drugs were kg (range 32-78 mg/kg) ( Table 2) .
comparable: 16.6 ± 5.5 (mean ± SD) for fl-artemether and 16.2 ± 3.6 for 0-arteether. The
Plasmodium falciparum-Aotus monkey test ED,, for 0-artemether was 7.1 mg/kg (95% CI sYstem = 3.7-13.5 mg/kg) and 11. umol/kg), the differences between the two drugs Aotus monkey model is considered to be the were not statistically significant. The monkeys best primate model for experimental treatment tolerated the drugs well at all dose levels, of blood-induced infections of human P.falciparum,17 it provides good predictability for the DISCUSSION potential efficacy of 0-arteether as an antimalarial agent in humans. Second, the fact that Tripathi and others recently reported on the 4-artemether has already been shown to be comparative efficacy of the blood schizontoci-highly effective in patients with malaria 4 . 6 prodal activity of a, 0, and a/0-arteether (a 30:70 vides further support for our belief that the in mixture of anomers) against P. c vnomolgi B in-vivo results can be generalized to the activity fection in the rhesus monkey. t They concluded of these compounds in human malaria. It is also that 0-and a/0-arteether have comparable ac-interesting to note that the ED 50 of 0-artemether tivity and are curative at a total dose of 15 mg/ of 7.1 mg/kg in the Aotus monkey is comparable kg given in three equally divided doses for three to the clinically effective curative dose of 0-ardays: they also concluded that a-arteether was temether in humans of 8.6-12 mg/kg (in a 50-slightly less active. Our findings are generally kg human receiving a dose of 480-600 mg inconsistent with theirs. In vitro, the a anomer of tramuscularly in divided dose for several arteether had somewhat lower activity than the days).
6 ,1i19 Considering that the two com-0 anomer. Otherwise, the a and 0 anomers of pounds are closely related chemically and that artemether and the 0 anomer of arteether showed their activities in our test systems are compaoverall comparable activity. The two in vivo rable, it is reasonable to conclude that they are efficacy models also showed that the 0 anomers likely to be equipotent in humans. This concluof artemether and arteether have comparable sion is consistent with the high likelihood that activity against malaria parasites.
a major contributor to the activity of both drugs These findings are important for further clin-in vivo may be a common metabolite such as ical development of 0-arteether. First, since the DHA. That DHA is a major metabolite of 0-ar-
